Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia.

Using transcriptomics to identify and validate novel biomarkers of human skeletal muscle cancer cachexia. Genome Med. 2010 Jan 15; 2(1):1.

View in: PubMed